The Asia Pacific Clinical Decision Support Systems Market would witness market growth of 12.8% CAGR during the forecast period (2021-2027).
A clinical decision support system (CDSS) aims to improve healthcare delivery by incorporating specific clinical knowledge, patient information, and other health data into medical decisions. Firstly, the features of an individual patient are matched to a computerized clinical knowledge base, and patient-specific assessments or recommendations are then offered to the doctor for a decision.
And secondly, CDSSs are most commonly employed at the point of care in the current healthcare landscape, allowing clinicians to combine their knowledge with information or suggestions offered by the CDSS. However, CDSS are being developed increasingly with the ability to utilize data and observations that would otherwise be unavailable or unintelligible to humans.
APAC is a region that is undergoing a significant number of developments very rapidly. This can be ascribed to countries like Australia, China, India, and Japan increasing their investments in the healthcare sector. Some of the growth catalysts for the regional market are increased R&D expenditure by governments of nations to increase the penetration of information technology in the medical area.
The China market dominated the Asia Pacific Clinical Decision Support Systems Market by Country 2020, and would continue to be a dominant market till 2027; thereby, achieving a market value of $607.5 million by 2027. The Japan market is anticipated to grow a CAGR of 12.1% during (2021 - 2027). Additionally, The India market would witness a CAGR of 13.4% during (2021 - 2027).
Based on Component, the market is segmented into Services, Hardware, and Software. Based on Product, the market is segmented into Standalone CDSS, Integrated CDSS with CPOE & E.H.R., Integrated E.H.R. with CDSS, and Others. Based on Delivery Mode, the market is segmented into On-premise Systems, Web-based Systems, and Cloud-based Systems. Based on Application, the market is segmented into Drug Allergy Alerts, Drug-drug Interactions, Clinical Guidelines, Drug Dosing Support, Clinical Reminders, and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
Free Valuable Insights: The Worldwide Clinical Decision Support Systems Market is Projected to reach USD 8.2 Billion by 2027, at a CAGR of 10.7%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Siemens Healthineers AG (Siemens AG), Cerner Corporation (Oracle Corporation), AllScripts Healthcare Solutions, Inc., General Electric (GE) Co. (GE Healthcare), NextGen Healthcare, Inc., Athenahealth, Inc. (Veritas Capital), Epic Systems Corporation, eClinicalWorks LLC, Change Healthcare, Inc., and Zynx Health, Inc. (Hearst Communications, Inc.).
By Component
By Product
By Delivery Mode
By Application
By Country
Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
Unique Offerings 